Antithrombin III (Functional Activity) — Plasma

Antithrombin (AT) is a major endogenous anticoagulant. Functional activity assays help diagnose hereditary or acquired AT deficiency, which is associated with increased venous thromboembolism risk.

Units Nonpregnant Adult 1st Trimester 2nd Trimester 3rd Trimester
% activity 70 – 130 89 – 114 88 – 112 82 – 116

In normal pregnancy, AT activity remains within or slightly below the standard range, with mild physiologic decreases most noticeable in the 3rd trimester and early postpartum.

Causes of Low Antithrombin III
  • Pregnancy-related / physiologic
    • Mild decrease in late pregnancy
    • Preeclampsia, severe preeclampsia, HELLP
    • Placental abruption, IUFD with DIC
    • Sepsis or severe infection
    • Heparin therapy (especially unfractionated heparin)
  • Congenital antithrombin deficiency
    • Type I: decreased antigen + activity (typically 40–60%)
    • Type II: normal antigen, reduced activity (qualitative defect)
    • Best tested postpartum or outside pregnancy
  • Acquired (non–pregnancy specific)
    • Liver disease
    • Nephrotic syndrome
    • Protein-losing enteropathy
    • Disseminated intravascular coagulation
    • Major surgery, trauma, ECMO
    • Malignancy or severe systemic inflammation
  • When results may be unreliable
    • Acute thrombosis
    • During heparin therapy
    • Late pregnancy / postpartum
    • Severe illness or sepsis

Marked reductions should prompt repeat testing when clinically stable and off heparin; family studies may help confirm hereditary deficiency.

References

  1. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326–31.
  2. Wallach J. Interpretation of Diagnostic Tests, 8th ed.
  3. Fischbach FT, Dunning MB. A Manual of Laboratory and Diagnostic Tests, 7th ed.
  4. Reviews on hereditary/acquired antithrombin deficiency and thrombophilia management.